REG-Misys PLC <MSY.L> Further re placing of shares

RNS Number:4041Q 
Misys PLC 
18 March 2008 
 
 
COMMUNICATION IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR 
INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN. 
 
MISYS PLC ("Misys" or the "Company") announces the results of conditional 
placing of 42,857,143 new ordinary shares by Misys at a placing price of 175 
pence per new ordinary share (the "Placing") 
 
18 March 2008 
 
Further to the announcement made earlier today (the "ABO Launch Announcement") 
regarding the opening of the accelerated bookbuild process in relation to the 
new ordinary shares in Misys (the "Placing Shares"), the books are now closed. 
The net proceeds from the Placing Shares which are conditionally placed, will be 
used to part finance the cash element of the transaction also announced earlier 
today by Misys, whereby Misys will combine Misys Healthcare with Allscripts 
Healthcare Solutions Inc. and acquire a controlling stake of 54.5 per cent. in 
the combined entity (calculated on a fully diluted basis) (the "Transaction"). 
The gross proceeds of the Placing are expected to be approximately £75 million. 
The market price of Misys' ordinary shares at close of business in London on 17 
March 2008 was 141.75 pence. 
 
Misys confirms that no Placing Shares have been conditionally placed with 
placees and therefore all of the Placing Shares, if issued, will be acquired by 
ValueAct Capital Master Fund L.P., acting through its general partner VA 
Partners I, LLC, ("ValueAct") pursuant to its underwriting commitment as 
described in the ABO Launch Announcement.  Upon acquisition of such Placing 
Shares, the percentage of the issued voting share capital of Misys controlled by 
affiliates within ValueAct's group is expected to increase to approximately 
25.8 per cent.  The Placing Shares represent approximately 8.5 per cent of 
Misys's issued ordinary share capital prior to the launch of the Placing. 
 
The Placing is conditional on, inter alia, the closing of the Transaction taking 
place before 31 December 2008. 
 
Application will be made for, and the placing is conditional on, admission of 
the Placing Shares to the Official List of the UK Listing Authority and to 
trading on the London Stock Exchange plc's main market for listed securities 
("Admission"). 
 
Following the conditions precedent to the Transaction being satisfied or waived, 
Misys will publish an announcement detailing the proposed date for the closing 
of the Placing and Admission. 
 
For further information, please contact: 
                                                                   18 March 2008 
Enquiries 
JPMorgan Cazenove Limited                                       +44 20 7588 2828 
Andrew Hodgkin 
Jonathan Wilcox 
 
This announcement and the information contained herein are not for release, 
publication or distribution, directly or indirectly, in or into the United 
States, Australia, Canada or Japan.  This announcement is not an offer to sell 
or a solicitation of an offer to buy the Placing Shares in the United States. 
The Placing Shares have not been and will not be registered under the US 
Securities Act of 1933, as amended (the "Securities Act") and may not be offered 
or sold, directly or indirectly, in the United States absent registration or an 
exemption from registration.  There will be no public offering of securities in 
the United States.  The Placing Shares have not been and will not be registered 
with any regulatory authority of any state within the United States. The 
placing, and the distribution of this announcement and other information in 
connection with the placing in certain jurisdictions, may be restricted by law 
and persons into whose possession any document or other information referred to 
herein comes should inform themselves about and observe any such restriction. 
Any failure to comply with these restrictions may constitute a violation of the 
securities laws of any such jurisdiction. 
 
JPMorgan Cazenove, which is authorised and regulated in the United Kingdom by 
the Financial Services Authority, is acting exclusively for the Company and no 
one else in connection with the Placing and the other matters referred to in 
this announcement.  JPMorgan Cazenove will not regard any other person as its 
client and will not be responsible to anyone other than the Company for 
providing the protections afforded to its clients nor for giving advice in 
relation to the Placing and the other matters referred to herein. 
 
This announcement includes statements that are, or may be deemed to be, 
"forward-looking statements".  These forward-looking statements can be 
identified by the use of forward-looking terminology, including inter alia the 
terms "believes", "plans", "expects", "may", "will", or "should" or, in each 
case, their negative or other variations or comparable terminology. 
 
These forward-looking statements include matters that are not historical facts 
and include statements regarding the Company's intentions, beliefs or current 
expectations concerning, among other things, the Company's results of 
operations, financial condition, liquidity, prospects, growth, strategies, the 
outlook for relevant markets and the proposed Transaction. By their nature, 
forward-looking statements involve risk and uncertainty because they relate to 
future events and circumstances.  A number of factors could cause actual results 
and developments to differ materially from those expressed or implied by the 
forward-looking statements. Forward-looking statements may and often do differ 
materially from actual results. Any forward-looking statements in this 
announcement reflect the Company's view with respect to future events as at the 
date of this announcement and are subject to risks relating to future events and 
other risks, uncertainties and assumptions relating to the Company's operations, 
results of operations, growth strategy and liquidity. 
 
Save as required by relevant law or regulation, the Company undertakes no 
obligation publicly to release the results of any revisions to any 
forward-looking statements in this announcement that may occur due to any change 
in its expectations or to reflect events or circumstances after the date of this 
announcement. Information in this announcement or any of the documents relating 
to the Placing should not be relied upon as a guide to future performance. 
 
 
 
 
                      This information is provided by RNS 
            The company news service from the London Stock Exchange 
END 
FURDGGMFVRDGRZM